1.
Decrease in cardiac rate and force of contraction is mediated by stimulation of
2.
Following is a direct-acting cholinomimetic agent
3.
Cholinesterase inhibitor used in the management of Alzheimer's disease is
4.
NOT a direct-acting cholinomimetic agent
5.
Following is an anticholinergic drug
6.
Adverse effect associated with the anticholinergic drugs is
7.
Anticholinergic drug commonly used to treat motion sickness is
8.
Following condition is a contraindication for the use of anticholinergic drugs
9.
Following is an indirect-acting sympathomimetic agent
10.
Sympathomimetic drug commonly used to treat anaphylactic shock is
11.
Clonidine is primarily used to treat
12.
Anticholinergic drug used in Parkinson’s disease to reduce tremors and rigidity is
13.
Anticholinergic drug used to manage symptoms of organophosphate poisoning is
14.
Role of pralidoxime (2-PAM) in the management of organophosphate poisoning is
15.
Non-selective beta-blocker among the following is
16.
Cardioselective (beta-1 selective) beta-blocker among the following is
17.
Adverse effect associated with the sudden discontinuation of beta-blockers is
18.
NOT a clinical indication of alpha-blockers
19.
Combined alpha and beta blocker indicated in the management of heart failure and angina is
20.
Carbonic anhydrase inhibitor used in the management of glaucoma is